Could the Next Blockbuster Drug Be Lab-Rat Free?news2023-03-07T08:00:08+00:00March 7th, 2023|The New York Times|
The ‘Wild West’ of Ketamine Treatmentnews2023-03-05T17:25:04+00:00March 5th, 2023|The New York Times|
A Statin Alternative Joins Drugs That Can Reduce Heart Attack Risknews2023-03-04T16:58:34+00:00March 4th, 2023|The New York Times|
Walgreens Says It Won’t Offer the Abortion Pill Mifepristone in Conservative Statesnews2023-03-03T22:35:56+00:00March 3rd, 2023|The New York Times|
More Doctors Can Now Prescribe Buprenorphine to Opioid Users. Will It Help?news2023-03-03T08:00:11+00:00March 3rd, 2023|The New York Times|
New Approaches to the Drug Overdose Crisisnews2023-03-02T20:17:00+00:00March 2nd, 2023|The New York Times|
Eli Lilly to Cut Insulin Price and Cap Monthly Out of Pocket Costs at $35news2023-03-02T03:22:18+00:00March 2nd, 2023|The New York Times|
Opioid Distributors Cleared of Liability to Georgia Families Ravaged by Addictionnews2023-03-02T02:54:45+00:00March 2nd, 2023|The New York Times|
FDA Panel Recommends 2 RSV Vaccines for Older Adultsnews2023-03-01T21:29:15+00:00March 1st, 2023|The New York Times|
Why Are Ketamine Ads Following Me Around the Internet?news2023-03-01T19:42:37+00:00March 1st, 2023|The New York Times|
